These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8141167)

  • 1. The role of glucose in diabetic hypertension: effects on intracellular cation metabolism.
    Barbagallo M; Resnick LM
    Am J Med Sci; 1994 Feb; 307 Suppl 1():S60-5. PubMed ID: 8141167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes, hypertension and atherosclerosis: pathophysiological role of intracellular ions.
    Barbagallo M; Novo S; Licata G; Resnick LM
    Int Angiol; 1993 Dec; 12(4):365-70. PubMed ID: 8207315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes mellitus, hypertension and ageing: the ionic hypothesis of ageing and cardiovascular-metabolic diseases.
    Barbagallo M; Resnick LM; Dominguez LJ; Licata G
    Diabetes Metab; 1997 Sep; 23(4):281-94. PubMed ID: 9342541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of aging on intracellular divalent cation metabolism: a link to the increased incidence of hypertension and non-insulin dependent diabetes mellitus in the elderly?
    Barbagallo M; Dominguez LJ; Putignano E; Barbagallo-Sangiorgi G; Resnick LM
    Arch Gerontol Geriatr; 1996; 22 Suppl 1():233-8. PubMed ID: 18653038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnesium metabolism in hypertension and type 2 diabetes mellitus.
    Barbagallo M; Dominguez LJ; Resnick LM
    Am J Ther; 2007; 14(4):375-85. PubMed ID: 17667214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose-induced alterations of cytosolic free calcium in cultured rat tail artery vascular smooth muscle cells.
    Barbagallo M; Shan J; Pang PK; Resnick LM
    J Clin Invest; 1995 Feb; 95(2):763-7. PubMed ID: 7860758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular calcium and magnesium metabolism in the pathophysiology and treatment of hypertension and related metabolic disorders.
    Resnick LM
    Am J Med; 1992 Aug; 93(2A):11S-20S. PubMed ID: 1387762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oral contraception and carbohydrate metabolism: III--practical implications].
    Hilal M
    Contracept Fertil Sex (Paris); 1986 Jan; 14(1):59-62. PubMed ID: 12341242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance and urinary excretion of sodium in hypertensive patients with non-insulin dependent diabetes mellitus.
    Singh SK; Sarkar D; Agrawal JK
    J Assoc Physicians India; 1999 Jul; 47(7):709-11. PubMed ID: 10778592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the pathophysiology of late onset non-insulin dependent diabetes mellitus. Current controversies and new insights.
    Vaag A
    Dan Med Bull; 1999 Jun; 46(3):197-234. PubMed ID: 10421979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular free magnesium in hypertension: relation to peripheral insulin resistance.
    Resnick LM; Gupta RK; Gruenspan H; Laragh JH
    J Hypertens Suppl; 1988 Dec; 6(4):S199-201. PubMed ID: 3241201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in calcium and magnesium levels of lymphocytes in patients with diabetes and hypertension].
    Mo Z; Zhang M; Guan Y; Jian W
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(5):471-3. PubMed ID: 12080688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between hypertension and subtle and overt abnormalities of carbohydrate metabolism.
    Sowers JR
    J Am Soc Nephrol; 1990 Sep; 1(3 Suppl 1):S39-47. PubMed ID: 16989076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome.
    Yamagishi S; Nakamura K; Takeuchi M
    Med Hypotheses; 2005; 65(1):152-4. PubMed ID: 15893133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance, hyperinsulinemia and hypertension.
    Weidmann P; de Courten M; Böhlen L
    J Hypertens Suppl; 1993 Dec; 11(5):S27-38. PubMed ID: 8158379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperinsulinemia and its sequelae.
    Simonson DC
    Horm Metab Res Suppl; 1990; 22():17-25. PubMed ID: 2202624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance and upper-normal glucose levels in hypertension: a review.
    Cubeddu LX; Hoffmann IS
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S52-5. PubMed ID: 11986895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.